Publications Bertram Müller-Myhsok

Kemlink, D.; Vavrova, J.; Högl, B.; Frauscher, B.; Polo, O.; Silander, K.; Müller-Myhsok, B.; Winkelmann, J.: Independent replication of association of restless legs syndrome to MEIS1, BTBD9 and MAP2K5/LBXCOR1 in the European population. Journal of Sleep Research 17 (Suppl. 1), p. 26 - 26 (2008)

Ludwig, K. U.; Schumacher, J.; Schulte-Körne, G.; König, I. R.; Warnke, A.; Plume, E.; Anthoni, H.; Peyrard-Janvid, M.; Meng, H.; Ziegler, A. et al.; Remschmidt, H.; Kere, J.; Gruen, J. R.; Mueller-Myhsok, B.; Nöthen, M. M.; Hoffmann, P.: Investigation of the DCDC2 intron 2 deletion/compound short tandem repeat polymorphism in a large German dyslexia sample. Psychiatric Genetics 18 (6), pp. 310 - 312 (2008)

Ludwig, K. U.; Roeske, D.; Schumacher, J.; Schulte-Körne, G.; König, I. R.; Warnke, A.; Plume, E.; Ziegler, A.; Remschmidt, H.; Müller-Myhsok, B. et al.; Nöthen, M. M.; Hoffmann, P.: Investigation of interaction between DCDC2 and KIAA0319 in a large German dyslexia sample. Journal of Neural Transmission 115 (11), pp. 1587 - 1589 (2008)

Keck, M. E.; Kern, N.; Erhardt, A.; Unschuld, P. G.; Ising, M.; Salyakina, D.; Müller, M. B.; Knorr, C. C.; Lieb, R.; Hohoff, C. et al.; Krakowitzky, P.; Maier, W.; Bandelow, B.; Fritze, J.; Deckert, J.; Holsboer, F.; Müller-Myhsok, B.; Binder, E. B.: Combined Effects of Exonic Polymorphisms in CRHR1 and AVPR1B Genes in a Case/Control Study for Panic Disorder. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 147B (7), pp. 1196 - 1204 (2008)

Heck, A.; Lieb, R.; Unschuld, P.; Ellgas, A.; Pfister, H.; Lucae, S.; Erhardt, A.; Himmerich, H.; Horstmann, S.; Kloiber, S. et al.; Ripke, S.; Müller-Myhsok, B.; Bettecken, T.; Uhr, M.; Holsboer, F.; Ising, M.: Evidence for associations between PDE4D polymorphisms and a subtype of neuroticism. Molecular Psychiatry 13 (9), pp. 831 - 832 (2008)

Müller-Myhsok, B.: Genome-wide linkage and genome-wide association - Can they be reconciled? Annals of Human Genetics 72, p. 687 - 687 (2008)

Horstmann, S.; Lucae, S.; Menke, A.; Ising, M.; Müller-Myhsok, B.; Holsboer, F.; Binder, E.: Association of GRIK4 and HTR2A genes with antidepressant treatment in the MARS cohort of depressed inpatients. European Neuropsychopharmacology 18 (Suppl. 4), pp. S214 - S215 (2008)

Kloiber, S.; Kohli, M. A.; Brueckl, T.; Ising, M.; Uhr, M.; Menke, A.; Müller-Myhsok, B.; Holsboer, F.; Lucae, S.: Variations in tryptophan hydroxylase 2 are associated with elevated risk for metabolic syndrome in depression. European Neuropsychopharmacology 18 (Suppl. 4), p. S296 - S296 (2008)

Schormair, B.; Kemlink, D.; Roeske, D.; Eckstein, G.; Xiong, L.; Lichtner, P.; Ripke, S.; Trenkwalder, C.; Zimprich, A.; Stiasny-Kolster, K. et al.; Oertel, W.; Bachmann, C. G.; Paulus, W.; Högl, B.; Frauscher, B.; Gschliesser, V.; Poewe, W.; Peglau, I.; Vodicka, P.; Vavrova, J.; Sonka, K.; Nevsimalova, S.; Montplaisir, J.; Turecki, G.; Rouleau, G.; Gieger, C.; Illig, T.; Wichmann, H. E.; Holsboer, F.; Mueller-Myhsok, B.; Meitinger, T.; Winkelmann, J.: PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nature Genetics 40 (8), pp. 946 - 948 (2008)

Horstmann, S.; Lucae, S.; Menke, A.; Kohli, M.; Bettecken, T.; Uhr, M.; Ripke, S.; Ising, M.; Müller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.: Association of GRIK4 and 5-HTR2A with antidepressant treatment in the MARS cohort of depressed impatients. International Journal of Neuropsychopharmacology 11 (Suppl. 1), pp. 112 - 113 (2008)

Ising, M.; Silja, A.; Lucae, S.; Siebertz, A.; Depping, A. M.; Modell, S.; Müller-Myhsok, B.; Holsboer, F.: Molecular genetics of individual differences: What can we learn for related disorders? International Journal of Psychology 43 (3-4), p. 195 - 195 (2008)

Schumacher, J.; König, I. R.; Schröder, T.; Duell, M.; Plume, E.; Propping, P.; Warnke, A.; Libertus, C.; Ziegler, A.; Müller-Myhsok, B. et al.; Schulte-Korne, G.; Nöthen, M. M.: Further evidence for a susceptibility locus contributing to reading disability on chromosome 15q15-q21. Psychiatric Genetics 18 (3), pp. 137 - 142 (2008)

Weber, F.; Fontaine, B.; Cournu-Rebeix, I.; Kroner, A.; Knop, M.; Lutz, S.; Müller-Sarnowski, F.; Uhr, M.; Bettecken, T.; Kohli, M. et al.; Ripke, S.; Ising, M.; Rieckmann, P.; Brassat, D.; Semana, G.; Babron, M. C.; Mrejen, S.; Gout, C.; Lyon-Caen, O.; Yaouanq, J.; Edan, G.; Clanet, M.; Holsboer, F.; Clerget-Darpoux, F.; Müller-Myhsok, B.: IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Journal of Neurology 255 (Suppl. 2), pp. 52 - 53 (2008)

Kemlink, D.; Plazzi, G.; Vetrugno, R.; Provini, F.; Polo, O.; Stiasny-Kolster, K.; Oertel, W.; Nevsimalova, S.; Sonka, K.; Högl, B. et al.; Frauscher, B.; Hadjigeorgiou, G. M.; Pramstaller, P. P.; Lichtner, P.; Meitinger, T.; Müller-Myhsok, B.; Winkelmann, J.; Montagna, P.: Suggestive evidence for linkage for restless legs syndrome on chromosome 19p13. Neurogenetics 9 (2), pp. 75 - 82 (2008)

Freilinger, T.; Bohe, M.; Wegener, B.; Müller-Myhsok, B.; Dichgans, M.; Knoblauch, H.: Expansion of the phenotypic spectrum of the CACNA1A T666M mutation: a family with familial hemiplegic migraine type 1, cerebellar atrophy and mental retardation. Cephalalgia 28 (4), pp. 403 - 407 (2008)

Ising, M.; Adena, S.; Binder, E.; Pfennig, A.; Schalling, M.; Mueller-Myhsok, B.; Modell, S.; Holsboer, F.: Genetic determinants of neurobiological vulnerability markers in depression. European Psychiatry 23 (Suppl. 2), p. S9 - S9 (2008)

Menke, A.; Lucae, S.; Kloiber, S.; Horstmann, S.; Bettecken, T.; Uhr, M.; Ripke, S.; Ising, M.; Müller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.: Polymorphisms in metabotropic glutamate receptor 1 are associated with major depressive disorder. Biological Psychiatry 63 (7 Suppl. S), pp. 83S - 84S (2008)

Seiderer, J.; Dambacher, J.; Leistner, D.; Tillack, C.; Glas, J.; Niess, J. H.; Pfennig, S.; Jürgens, M.; Müller-Myhsok, B.; Göke, B. et al.; Ochsenkühn, T.; Lohse, P.; Reinecker, H. C.; Brand, S.: Genotype-phenotype analysis of the CXCL 16 p.Ala181Val polymorphism in inflammatory bowel disease. Clinical Immunology 127 (1), pp. 49 - 55 (2008)

Seiderer, J.; Elben, I.; Diegelmann, J.; Glas, J.; Stallhofer, J.; Tillack, C.; Pfennig, S.; Jürgens, M.; Schmechel, S.; Konrad, A. et al.; Göke, B.; Ochsenkühn, T.; Müller-Myhsok, B.; Lohse, P.; Brand, S.: Role of the novel th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.Hisl6lArg polymorphism in IBD. Inflammatory Bowel Diseases 14 (4), pp. 437 - 445 (2008)

Weber, F.; Fontaine, B.; Cournu-Rebeix, I.; Kroner, A.; Knop, M.; Lutz, S.; Müller-Sarnowski, F.; Uhr, M.; Bettecken, T.; Kohli, M. et al.; Ripke, S.; Ising, M.; Rieckmann, P.; Brassat, D.; Semana, G.; Babron, M. C.; Mrejen, S.; Gout, C.; Lyon-Caen, O.; Yaouanq, J.; Edan, G.; Clanet, M.; Holsboer, F.; Clerget-Darpoux, F.; Müller-Myhsok, B.: IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes and Immunity 9 (3), pp. 259 - 263 (2008)